The assessment, documentation, and/or procedures for considering the resale of returned drugs were inadequate.
Inspection Record
2579364 Ontario Inc. (dba Pace Pharmacy) — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
The temperature and/or humidity control was inadequate.
The written procedures for recalls were inadequate.
The premises were not designed, constructed, and/or maintained to prevent the entry of pests and/or foreign material into the building.
The computerized system used to manage product inventory and distribution records to support recalls was not validated.
About this record
Extracted automatically from the document of the Health Canada inspection on 2022-01-25. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
